A clinical trial was recently launched by the Cannabis Research Institute of South Africa (CRI), in partnership with Releaf Cannabis E-Clinics, with the goal of observing how medical cannabis can help treat opioid addiction. The duration of the trial will last for one year as it examines how cannabis affects a patient’s chronic pain. According […]
Last summer, Project CBD helped recruit subjects for a large-scale clinical study to assess the safety and efficacy of the daily use of cannabidiol. Good news: Contrary to FDA warnings, preliminary results of the ValidCare study show “no clinical evidence of liver disease in any of the participants.”
Project CBD seeks volunteers to assess the safety and efficacy of cannabidiol.